In Vitro Diagnostics Market is Expected to Reach USD 74.2 Billion Globally in 2018: Transparency Market Research

nitinsirsat's picture
Printer-friendly versionPrinter-friendly versionPDF versionPDF version

Transparency Market Research includes new market research report "In Vitro Diagnostics Market" to its huge collection of research reports


Albany, New York, USA., July 24, 2014 - (PressReleasePoint) -According to a new market report published by Transparency Market Research "InVitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," market was valued at USD 46.0 billion in 2011 and is expected to reach an estimated value of USD 74.2 billion in 2018, growing at a CAGR of 7.1% from 2012 to 2018.

 

Browse the full report at http://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

 

In vitro diagnostics (IVDs) provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. Rising number of patients suffering from infectious and chronic diseases such as sexually transmitted diseases, chronic obstructive pulmonary disease, diabetes and cancer is the most significant growth driver of this market. In addition, factors such as increasing global healthcare expenditure and demand for rapid, minimally invasive and non-invasive diagnostic tools & techniques are driving the market as well.

 

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1395

 

In 2011, the North America IVD market held the second largest share of the global market at approximately 40%. The Asia-Pacific IVD market is expected to outperform all geographies in terms of growth rate during the forecast period. Presence of large patient pool and rising healthcare expenditure in these regions are responsible for this growth.

 

The clinical chemistry segment of the market held the largest market share across all major geographic regions such as the U.S., China and India in 2011. However, increase in demand for molecular diagnostics in the IVD market is expected to cut into the market share of clinical chemistry by 2018.

 

Browse all Medical Devices Market Research Reports@ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.htm

 

In 2011, Roche Diagnostics (Roche Group) held the largest share in the global in vitro diagnostics market followed by Siemens Healthcare (Siemens AG). Some of the other major companies involved in the development, manufacturing and distribution of in vitro diagnostics are Johnson & Johnson, Beckman Coulter Inc., Becton Dickinson and Company, Gen-Probe Incorporated and Thermo Fisher Scientific Corporation.

 

Browse Blog https://tmrresearch.wordpress.com/


Press Contact:
SheelaAK
Transparency Market Research 90 State Street, Suite 700, Albany
15186181030
http://www.transparencymarketresearch.com
*****@**a**p**e**y**r**t**s**r**.com
Email partially hidden to block spam. Please use the contact form here.
Contact SheelaAK
Email the contact person for this press release. Do not send spam or irrelevant message.
1 + 2 =


News Source : In Vitro Diagnostics Market is Expected to Reach USD 74.2 Billion Globally in 2018: Transparency Market Research
Copy this html code to your website/blog to embed this press release.

Comments

Post new comment

2 + 10 =